Start Date
September 15, 2009
Primary Completion Date
January 17, 2014
Study Completion Date
January 17, 2014
Fesoterodine Oral Product
After urological and neurological evaluation, those patients who meet he US approved indications for prescribing will be placed on a regimen of Toviaz 4 mg/day taken once daily with liquids and swallowed whole. The Toviaz dose may be increased to 8 mg/day if there is not therapeutic response on the 4 mg/day.
Vanderbilt Univiersity, Nashville
Collaborators (1)
Pfizer
INDUSTRY
Saint Thomas Health
OTHER